(1R,2R)-2-(Pyridin-3-yl)cyclopropane-1-carboxylic acid, 5g

2-Methoxy-6-methylpyrimidin-4-amine, 97.0%, 1g

2-hydrazino-5-methyl-4-(2-thienyl)pyrimidine, 95.0%, 1g

n-Phenylpiperazine-1-carboxamide, 95+%, 10g

ROTI®Pol TaqS, 100 µl, 1 x 100 µl

1-Phenylpyrrole>98.0%(GC)5g

2-Chloro-3-bromo-6-fluorotoluene, 95.0%, 100g

[1-(6-Diethylamino-pyrimidin-4-yl)-piperidin-4-ylmethyl]-carbamic acid tert-butyl ester, 95.0%, 250mg

1-bromo-3-(cyclohexyloxy)benzene, 10g

6-Methyl-1,3-benzoxazole-2(3H)-thione>98.0%(GC)(T)5g

1-(4-Methoxy-phenoxy)-3-methylamino-propan-2-ol, 97%, 1g

1',3',3'-Trimethylspiro[chromene-2,2'-indoline], 98%, 250mg

2-Acetylbenzo[b]thiophene>98.0%(GC)5g